SCHEMBL18292683

SCHEMBL18292683

Cc1nc2ccccc2nc1Oc1ccc(Cl)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 3/20 0.46
▸ EGFR P00533 1/20 0.45
▸ KDM4E B2RXH2 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ SLC6A4 P31645 3/20 0.39
▸ HTR2A P28223 2/20 0.39
▸ KCNH2 Q12809 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18796308 0.83 EGFR (0.47) HRH4EGFRKDM4EHPGDCYP1A2
SCHEMBL18795929 0.75 MAPT (0.50) KDM4EHPGDALDH1A1MAPTL3MBTL1
SCHEMBL16795314 0.73 ALDH1A1 (0.54) KDM4EHPGDCYP1A2ALDH1A1MAPT
SCHEMBL18796096 0.72 KDM4E (0.44) HRH4KDM4EHPGDCYP1A2CYP2C9
SCHEMBL10904835 0.72 L3MBTL1 (0.50) HRH4KDM4EHPGDCYP1A2CYP2C9
SCHEMBL18796467 0.71 L3MBTL1 (0.40) HRH4EGFRKDM4EHPGDCYP1A2
SCHEMBL18647201 0.71 PPARG (0.49) HPGDCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL15385004 0.70 SLC6A4 (0.47) HPGDCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL18796221 0.68 L3MBTL1 (0.42) KDM4EHPGDALDH1A1MAPTL3MBTL1
SCHEMBL25000023 0.67 SLC6A4 (0.44) HPGDCYP1A2CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108349897-B Trisubstituted silylphenoxyheterocycles and analogs 拜耳作物科学股份公司 2022-03-04 — — CN claimed
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP claimed
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP disclosed
US-20160354375-A1 CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES ELECTROPHORETICS LIMITED (GB) 2016-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160354375-A1 CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES CSNK1G1, CSNK1A1, CSNK1D HRH4 4165/4885EGFR 1834/4885KDM4E 1514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback